Sunshine Biopharma Inc. SEC filings SBFM
Sunshine Biopharma Inc. has 428 filings in SEC EDGAR's recent list, going back to May 25, 2007. Its latest annual report, Form 10-K, was filed on Apr 3, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 14, 2026 (shareholder vote results). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B4 | Prospectus | Oct 9, 2026 | — |
| S-1 | Registration statement | Oct 2, 2026 | — |
| 424B3 | Prospectus | Sep 8, 2026 | — |
| S-1 | Registration statement | Aug 28, 2026 | — |
| 424B5 | Prospectus supplement | Jul 20, 2026 | — |
| 424B4 | Prospectus | May 19, 2026 | — |
| S-1 | Registration statement | May 12, 2026 | — |
| 424B3 | Prospectus | Aug 12, 2025 | — |
| S-1 | Registration statement | Aug 5, 2025 | — |
| POS AM | Post-effective amendment #2 | Jul 25, 2025 | — |
| 424B5 | Prospectus supplement | Apr 3, 2025 | — |
| S-3 | Shelf registration | Jan 6, 2025 | — |
| 424B4 | Prospectus | Nov 12, 2024 | — |
| POS AM | Filing | Nov 6, 2024 | — |
| 424B4 | Prospectus | Feb 14, 2024 | — |
| S-1/A | Amended registration statement | Feb 9, 2024 | — |
| S-1 | Registration statement | Feb 1, 2024 | — |
| S-8 | Employee stock plan registration | Jan 8, 2024 | — |
| 424B3 | Prospectus | Jun 5, 2023 | — |
| S-3 | Shelf registration | May 25, 2023 | — |
| 424B3 | Prospectus | May 20, 2022 | — |
| S-3 | Shelf registration | May 10, 2022 | — |
| 424B3 | Prospectus | Apr 8, 2022 | — |
| S-3 | Shelf registration | Mar 30, 2022 | — |
| 424B4 | Prospectus | Feb 17, 2022 | — |
| S-1/A | Amended registration statement | Feb 14, 2022 | — |
| S-1/A | Amended registration statement | Feb 9, 2022 | — |
| S-1/A | Amended registration statement | Feb 3, 2022 | — |
| S-1/A | Amended registration statement | Jan 24, 2022 | — |
| S-1 | Registration statement | Sep 9, 2021 | — |
| S-1 | Registration statement | Oct 9, 2018 | — |
| 424B3 | Prospectus | Jul 28, 2014 | — |
| S-1/A | Amended registration statement | Jul 3, 2014 | — |
| S-1 | Registration statement | May 22, 2014 | — |
| S-4 | Registration for a merger or exchange | Jan 31, 2014 | — |
| S-4 | Registration for a merger or exchange | Oct 23, 2013 | — |
| 424B3 | Prospectus | Feb 12, 2008 | — |
| S-1/A | Amended registration statement | Feb 12, 2008 | — |
| 424B3 | Prospectus | Nov 6, 2007 | — |
Showing 39 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- SBFM (Nasdaq), SBFMW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- CO
- Headquarters
- Fort Lauderdale, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1402328
- Former names
- Sunshine Biopharma, Inc (until Oct 17, 2024); Mountain West Business Solutions, Inc (until Nov 2, 2009); mountain west business solutions,inc (until Oct 19, 2007); mountain state business solutions,inc (until May 25, 2007)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.